Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion type Assertion NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_head.
- NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion description "[Recombinant soluble myeloid differentiation protein-2 (MD-2) complemented normal plasma and allowed LPS activation of epithelial cells to levels measured with `septic` plasma, whereas soluble MD-2-depleted plasma lost its effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_provenance.
- NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion evidence source_evidence_literature NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_provenance.
- NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion SIO_000772 15328161 NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_provenance.
- NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion wasDerivedFrom befree-20140225 NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_provenance.
- NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_assertion wasGeneratedBy ECO_0000203 NP314142.RAn4lduGMyCeiuVML71bBHvozx6y4WfKsvwuyjndDglI4130_provenance.